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Abstract
Three different matrix (M) proteins termed M1, M2 and M3 have been described in cells
infected with vesicular stomatitis virus (VSV). Individual expression of VSV M proteins
induces an evident cytopathic effect including cell rounding and detachment, in addition to a
partial inhibition of cellular protein synthesis, likely mediated by an indirect mechanism.
Analogous to viroporins, M1 promotes the budding of new virus particles; however, this pro-
cess does not produce an increase in plasma membrane permeability. In contrast to M1,
M2 and M3 neither interact with the cellular membrane nor promote the budding of double
membrane vesicles at the cell surface. Nonetheless, all three species of M protein interfere
with the transport of cellular mRNAs from the nucleus to the cytoplasm and also modulate
the redistribution of the splicing factor. The present findings indicate that all three VSV M
proteins share some activities that interfere with host cell functions.
Introduction
Vesicular stomatitis virus (VSV) is the prototype member of the Vesiculovirus genus that
belongs to the Rhabdoviridae family. VSV contains a single-stranded RNA genome of negative
polarity that encodes five proteins: nucleocapsid (N), phosphoprotein (P), matrix (M) protein,
glycoprotein (G) and large (L) viral polymerase [1]. The first event during VSV gene expression
is the transcription of each viral gene by the RNA-dependent-RNA polymerase, which consists
of a complex of L and P proteins bound to the 30 end of the viral RNA. VSV mRNAs, which are
capped at the 50 end and polyadenylated at the 30 end [2], are subsequently translated by the
host cell machinery to produce all viral proteins that are necessary for the replication of the
viral genome and its assembly, and eventual release of new virions. Apart from structural and
regulatory roles, these proteins also contribute to the cytopathogenesis associated with VSV
infection [3].
The interaction of M protein with the viral ribonucleoprotein complex is essential for pack-
aging of viral RNA and assembly of virions. In addition, M protein is associated with the inner
leaflet of the plasma membrane and is involved in the budding of the “bullet-shaped” viral par-
ticles [4]. The presence of two late (L) budding domains, PPPY and PSAP, within the first 40
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amino acids of the N-terminal region of the M protein, contributes to virus egress from
infected cells. Recent studies have shown that the PPPY and PSAP motifs mediate the recruit-
ment of host cell factors, E3 ubiquitin ligase Nedd4 and Tsg101, respectively, which are compo-
nents of the ESCRT1 (endosomal sorting complex required for transport 1) complex, and are
required for the late step of virus budding (i.e. the fission between the viral and cell membrane)
[5–7].
M protein plays multiple roles in VSV infection, and is the viral component responsible for
the majority of the cytopathic effects observed in infected cells. A previous study by Jayakar
et al. reported that the M gene encodes two additional polypeptides, denoted M2 and M3, in
addition to the 229-amino acid long full length M protein (referred to as M1) [8]. M1 and the
smaller M2 and M3 proteins are generated from the same ORF by a mechanism of translation
initiation that involves alternative utilization of downstream AUG codons that encode methio-
nine at positions 33 and 51. These shorter forms of M1 protein share an identical C-terminal
amino acid sequence and induce cell rounding, a cytophatic effect that leads eventually to
death of VSV-infected cells [8]. Apart from their involvement in viral cytopathogenesis, the
function of M2 and M3 remains largely unknown. Other cytopathic effects triggered by M1
during VSV infection include disorganization of the cytoskeleton, inhibition of cellular gene
expression and induction of apoptosis [9–14]. The blockade of host gene expression by M1
protein has been shown to occur at multiple levels, e.g. M1 inhibits transcription and nuclear
export of different RNAs [15–17]. Translation of host cell proteins is also affected during VSV
infection [18]; however, the fact that this is not observed when M1 is expressed in the absence
of the other viral proteins suggests that inhibition of protein synthesis is a consequence of the
suppression of both transcription and mRNA transport, rather than a direct effect of M1 [10,
19, 20]. Although a number of studies have described multiple roles for M1, there is still no evi-
dence for a functional contribution of M2 and M3 proteins. In the present study, we carried
out a comparative analysis designed to assess the involvement of M2 and M3 viral products in
the functions ascribed to full length M1 protein. We found that alternative expression of
shorter forms of M1 is likely not involved in the final step of virus budding, but rather induces
cell rounding and partially inhibits translation in cells susceptible to VSV infection. These cyto-
pathic effects mediated by all the three M proteins correlate with a block of cellular mRNA
export from the nucleus to the cytoplasm and a selective alteration in the nuclear localization
of hnRNP H, a host factor involved in mRNA splicing.
Results
Expression of VSVM1 protein and two additional translation products,
M2 and M3, in a cell free-system and in BHK-T7 cells
It was previously demonstrated that M2 and M3 proteins are not cleavage products fromM1
protein, but rather they are synthesized from the MmRNA by alternative initiation at internal
AUG codons [8]. To investigate the function of VSV M2 and M3 polypeptides in mammalian
cells, we utilized different expression systems. The first goal of our study was to analyze the
expression of the three VSV M proteins fromMmRNA in a cell-free system. Three plasmids
were constructed using the pTM1 backbone vector that contains the T7 polymerase promoter
and the encephalomyocarditis virus (EMCV) internal ribosome entry site (IRES), followed by
sequences encoding either the full-length M1 protein, M2 (commencing at the AUG encoding
Met33) or M3 (commencing at the AUG encoding Met51) (Fig 1A). These plasmids were des-
ignated pTM1-M1, pTM1-M2 and pTM1-M3. The corresponding mRNAs encoding the dif-
ferent M proteins were obtained by in vitro transcription and subsequently used for in vitro
translation assays in RRL. The plasmid pTM1-2C, encoding the poliovirus (PV) 2C protein,
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Fig 1. Expression of VSVM1, M2 and M3 proteins in a cell-free system and in mammalian cells. (A)
Schematic representation of M mRNA and M1, M2 and M3 proteins of VSV. (B) Translation of VSVM
proteins in rabbit reticulocyte lysates. 100 ng of mRNA obtained by in vitro transcription from constructs
pTM1-M1, pTM1-M2 and pTM1-M3 was incubated with RRLs at 30°C for 2 h with [35S]Met/Cys. mRNAs
obtained from pTM1-2C (encoding poliovirus 2C protein) or a pTM1-empty plasmid were used as positive and
negative controls, respectively. A plasmid no linearized (pTM1-M1c) was used as a reaction control. Protein
expression was analyzed by SDS-PAGE (15%), fluorography and autoradiography. (C) Expression of VSVM
proteins in BHK-T7 cells. Cells were transfected with pTM1-M1, pTM1-M2 or pTM1-M3 for 2 h, or were
infected with VSV at a multiplicity of infection of 10 pfu/cell in DMEMwithout serum for 1 h at 37°C.
Subsequently, the medium was removed and both infected and transfected cells were incubated with DMEM
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and the empty plasmid, pTM1, were used as positive and negative expression controls, respec-
tively. Results showed that M1 mRNA preferentially directed the synthesis of M1; however, M2
and M3 protein synthesis was also evident, albeit at lower levels (Fig 1B). Moreover, translation
of M2 mRNA largely directed the synthesis of a protein with an identical migration pattern as
the M2 protein obtained fromM1 mRNA, and also the synthesis of a smaller product with the
size expected for M3. Further, as observed for M2 synthesis, the expression of M3 fromM3
mRNA was more robust as compared with that obtained fromM2 mRNA (Fig 1B). These
results are consistent with expression of M2 and M3 by alternative initiation at AUG codons
encoding Met-33 and Met-51. Subsequently, the expression of the three M proteins was tested
in mammalian cells. BHK-T7 cells, which are susceptible to VSV infection and constitutively
express the T7 RNA polymerase, were employed. BHK-T7 cells were transfected with the plas-
mids encoding M1, M2 and M3, or empty pTM1 as a control, and the synthesis of M proteins
in BHK-T7 and in VSV-infected cells was compared. Expression of the VSV M proteins was
analyzed by Western blot using a mouse monoclonal antibody specific for VSV M1 protein
that also recognizes M2 and M3 [21]. As illustrated in Fig 1C, M1 and the alternative products,
M2 and M3, were expressed efficiently from the corresponding transfected plasmids in
BHK-T7 cells and the quantity of M1 present was similar to that observed in VSV infected cells
at 7 hpi. However, the quantity of M2 and M3 protein synthesized in VSV infected cells was
much less than that obtained when pTM1-M2 or pTM1-M3 were transfected (Fig 1C).
Cytotoxicity associated with VSV infection has been ascribed to the expression of M1 and
also to M2 and M3 [8]. To assess the degree of cytotoxicity induced by the synthesis of M1, M2
and M3 proteins in BHK-T7 cells, we studied the morphology of transfected cells at different
time points by optical microscopy. Consistent with previous results, the expression of each M
protein correlated with the induction of cell rounding and detachment of transfected cells
(Fig 2).
Membrane permeabilization by VSVM1, M2 and M3
Cell rounding is typically provoked by certain viral proteins that are highly cytotoxic and is
particularly evident with membrane-active proteins. We therefore examined the impact of M
protein expression on membrane functions such as the maintenance of membrane permeabil-
ity and the induction of vesicle budding at the plasma membrane. VSV M protein is involved
in virus budding, as occurs with a family of viral proteins known as viroporins [22, 23]. Thus,
viroporins possess ion channel activity upon their oligomerization, and assemble to form pores
in cell host membranes. This activity alters membrane permeability and it is important for
virus budding [22, 23]. VSV M1 interacts with cellular membranes both through a carboxy-ter-
minal and a basic amino-terminal domain, which allows the establishment of electrostatic
interactions [24, 25]. Moreover M1 can self-interact, forming oligomers, and is involved in the
budding of viral particles at the plasma membrane [25–27]. Therefore, both VSV M protein
and viroporins exhibit several analogies, including oligomerization membrane interaction and
promotion of virus budding. These parallels with viroporins prompted us to study whether
M1, or the alternative M2 or M3 proteins, forms pores in the cell membrane and behaves as a
viroporin. To test this, we used the aminoglycoside antibiotic hygromicin B (HB) to determine
alterations in membrane permeability. HB does not permeate into cells under normal
containing 5% FCS at 37°C. Cells were lysed 6 h later and expression of viral proteins was analyzed by
Western blot using a mouse monoclonal antibody specific for M1 protein that also recognizes M2 and M3
proteins. Specific products with molecular weight higher than that of M1 might represent oligomeric forms of
M proteins. Bands corresponding to different M proteins or poliovirus 2C are indicated with arrows.
doi:10.1371/journal.pone.0131137.g001
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conditions, but readily crosses the plasma membrane upon viroporin expression, and inhibits
protein translation [28]. The HB assay was performed in BHK-T7 cells transfected with plas-
mids encoding M proteins or PV 2B protein, an acknowledged viroporin that was used as a
positive control. As expected, the PV 2B viroporin induced potent membrane permeabilization
to HB, detected as a drastic reduction in protein translation (Fig 3A). However, this effect was
not observed upon expression of M1, M2 or M3, or in control cells transfected with pTM1
(Fig 3A). To further assess membrane permeabilization, an additional approach based on Sind-
bis virus (SINV) replicons was used [29]. In this system, the sequence of the protein of interest
(X) is cloned in-frame downstream of the SINV capsid protein (C), which possesses autopro-
teolytic activity. The shut-off of cellular translation by the non-structural proteins of the SV
replicon is followed by the synthesis of a subgenomic RNA that encodes the precursor C-X.
Thus, upon expression and cleavage of C-X, both the SV C and the protein immediately down-
stream are present in equimolar amounts. This approach allows for a simple quantification of
SINV C protein as a metric to determine the entry of HB exclusively in cells that express the
Fig 2. Cytotoxic effect mediated by expression of VSVM proteins. BHK-T7 cells were transfected with pTM1 empty (mock), pTM1-M1, pTM1-M2 or
pTM1-M3 for 2 h. Cells were then washed and incubated in DMEM containing 5% FCS until they were fixed at 6, 18 and 24 h post transfection (hpt). Cell
morphology was examined with a phase-contrast microscope.
doi:10.1371/journal.pone.0131137.g002
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Fig 3. VSVM proteins do not alter cell membrane permeability. (A) BHK-T7 cells were transfected with
pTM1 empty plasmid or pTM1 constructs encoding M1, M2 or M3 proteins. As a positive control, cells were
transfected with pTM1-2B (encoding poliovirus 2B viroporin). The medium was removed 2 h later and fresh
DMEM containing 5% FCS was added. Cells were pre-treated 15 h after transfection with 0.5 mM of the
translation inhibitor hygromycin B (HB) for 15 min. Then, cells were metabolically labelled with [35S]Met/Cys
for 45 minutes in the presence or absence of HB. Samples were processed by SDS-PAGE (17.5%),
fluorography and autoradiography. (B) BHK-21 cells were mock transfected or electroporated with SV-
derived mRNA replicons: Rep C, Rep C+M1 or Rep C+6K, obtained by in vitro transcription from their
corresponding DNA templates. Cells were pre-treated with HB and metabolically labeled as indicated in (A).
Numbers below each lane indicate the percentages of protein synthesis calculated by dividing the
densitometric values for HB-treated cells by the values for untreated cells. A cellular protein band in mock
transfected cells, or the band corresponding to the SV C protein in replicon transfected cells, was quantified
by densitometric scanning, respectively. Bands corresponding to SV C and VSVM1 protein are indicated
with arrows. Detection of α-tubulin served as loading control.
doi:10.1371/journal.pone.0131137.g003
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protein of interest. To test membrane permeabilization by VSVM proteins, the corresponding
SINV replicon bearing the VSV M1 sequence (Rep C+M1) was constructed. Additionally,
SINV replicons encoding SINV 6K viroporin (Rep C+6K) or C alone (Rep C) were used as pos-
itive and negative controls of membrane permeabilization, respectively. As shown in Fig 3B,
expression of SINV C protein did not affect membrane permeability to HB, whereas SINV 6K
viroporin provoked the entry of HB and a resultant strong blockade in translation. Notably,
VSV M1 protein did not provoke any significant membrane permeabilization to HB at 16 hpt.
These results are in agreement with previous experiments performed using an in vitro system
with artificial membranes [30] and demonstrate that, in contrast to viroporins, none of the
VSV M proteins exhibit an ability to disrupt membrane permeability despite the fact that they
are integral membrane proteins. These findings indicate that neither the integration of a viral
protein into the plasma membrane, nor its oligomerization capacity, is sufficient to perturb
membrane permeability.
Induction of vesicle budding at the plasma membrane by VSV M proteins
VSVM1 protein mediates the budding of viral particles at the plasma membrane in VSV-
infected cells [31]. Indeed, the PPPY motif located in M1 protein (amino acids 24 to 27) is a
functional late-budding domain. However, the downstream PSAP motif (amino acids 37 to 40)
does not display such an activity in VSV-infected BHK-21 cells [5, 32–34]. The fact that M2
and M3 differ fromM1 in the amino-terminal domain prompted us to compare the ability of
the three proteins to induce vesicle formation and budding from the plasma membrane. Thus,
BHK-T7 cells were transfected with plasmids encoding M1, M2 or M3 sequences, or an empty
plasmid that served as a negative control, and the intracellular location of the proteins was ana-
lyzed by immuno-gold labeling and transmission electron microscopy. Unquestionably, M1
was located at the plasma membrane, and was particularly concentrated at sites of vesicle
budding where intracellular vesicles were in close proximity (Fig 4A–4F). Quantitation of gold
granules per cm of plasma membrane provided the following average values: 1.7, 20, 1.5 and
1.7 for vector alone, M1, M2 and M3, respectively, obtained as the mean values of the measure-
ment of three cells. The gold granules distribution on plasma membrane was statistically signif-
icant (p< 0.01) from that cells transfected with empty vector, M2 or M3 compared to cells
transfected with M1. Moreover, the visualization of different stages of vesicle formation and
egress allowed us to strengthen the concept of the double membrane-nature of the vesicles
released from cells expressing M1 protein (Fig 4A–4F) [35]. The self-interaction between the
VSV M1 proteins residing at the plasma membrane and, likely, M1 located at the membrane of
intracellular vesicles, might function as a “zipper-like” structure, allowing close contact of the
two membranes (Fig 4A–4C). Supporting this possibility, we observed a regular and paired dis-
tribution of gold particles at regions of the plasma membrane where intracellular vesicles are
recruited and subsequent budding occurs (Fig 4B). Additionally, the interaction of M1 with the
ESCRT machinery could eventually trigger the scission and final release of the double-mem-
brane vesicles. This suggested that VSVM1 protein exhibits the ability per se to induce the bud-
ding of vesicles at the plasma membrane (Fig 4A–4F). However, this intrinsic budding activity
was not observed when M2, lacking the PPPY motif, or M3, lacking both L-domains, were
transfected (Fig 4H and 4I). Although we could observe intracellular vesicles near the plasma
membrane, neither M2 nor M3 were detected at those sites or at the cell surface. Since these
findings indicated that VSV M proteins have a diverse localization, we used immunofluores-
cence to determine their subcellular localization. Results showed that VSV M1 protein was
detected mainly at the plasma membrane, in intracellular membranes and in dot-like struc-
tures, and also at the nuclear periphery (Fig 5). In contrast, M2 and M3 remained in the
Activity of VSVM Proteins on Cell Functions
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cytoplasm (Fig 5). Collectively these results indicated that both the localization of VSVM1 pro-
tein at the plasma membrane and its intrinsic function to promote budding required the pres-
ence of the first 32 residues at its N-terminus, including the PPPY motif. It is therefore unlikely
that M2 and M3 are involved in virus budding at the cell surface. Nevertheless, the intracellular
localization of these proteins might support their participation in alternative functions
described for M1 other than budding.
Fig 4. Induction of vesicle budding from the plasmamembrane by VSVM proteins. BHK-T7 cells were transfected for 2 h with pTM1 encoding M1
(A-F), pTM1 empty (G), M2 (H) or M3 (I). Cells were fixed 6 h after transfection and immunodetection of VSVM proteins was performed using specific
monoclonal antibodies and the corresponding mouse-secondary antibodies coupled to gold particles. Cells were visualized with a transmission electron
microscope. Arrows indicate sites of vesicle budding at the plasmamembrane (A-E) where M1 protein is concentrated, as well as vesicles already released
from the cells (F). Statistical analyses of the gold granules distribution was carried out by unpaired (two-tailed) Student t-test. p < 0.01 using the Stata
Program Version 11.0.
doi:10.1371/journal.pone.0131137.g004
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Effect of VSV M proteins on translation
Because VSV M1 has been shown to block host gene expression, we wished to assess the poten-
tial involvement of M2 and M3 proteins in this process. Initially, the impact of the three
Fig 5. Subcellular localization of VSV M proteins. BHK-T7 cells were transfected for 2 h with pTM1
encoding VSVM1 (A-D), M2 (E-F) or M3 (G-H), and fixed 6 h later. Expression and localization of viral
proteins were analyzed by immunofluorescence using specific monoclonal antibodies against M1 that also
recognize M2 and M3, and the corresponding mouse secondary antibody conjugated to Alexa 488.
Localization of M1 in intracellular membranes and dot-like structures at the nuclear envelope or at the cell
surface is shown in panels A, B and C, respectively. Localization of M2 and M3 in intracellular compartments
(E and G) or surrounding the nucleus (F and H) is shown. Images were acquired with an Axiovert microscope
connected to a digital camera.
doi:10.1371/journal.pone.0131137.g005
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proteins on mRNA translation was measured. Since our previous findings showed that cytotox-
icity induced by VSVM proteins increased in a time-dependent manner, we reduced the time
of expression of VSVM proteins in order to analyze their effect on endogenous cellular transla-
tion. As a positive control for this assay PV 2Apro was used as representative viral protein that
inhibits cap-dependent translation of mRNAs by cleavage of eIF4GI with a concomitant stimu-
lation of translation driven by picornavirus IRESs [36]. To study the impact of VSV M proteins
on translation, BHK-T7 cells were transfected with pTM1 plasmids and cells were metaboli-
cally labeled at 5 hpt to measure protein synthesis. As anticipated, a clear shut-off of cell trans-
lation accompanied by the efficient cleavage of eIF4GI was observed in cells expressing PV
2Apro (Fig 6A). The stimulatory effect of PV 2Apro on translation of uncapped mRNAs was
also evident upon co-transfection of pTM1 plasmids encoding the different M proteins and
containing the EMCV-IRES. In this case, the synthesis of M proteins was more efficient than in
the absence of PV 2Apro (Fig 6A). The expression of VSV M proteins only partially inhibited
the synthesis of cellular proteins, with a 30% reduction relative to cells transfected with empty
plasmid (Fig 6A). However, this effect was not comparable to the inhibition observed with PV
2Apro (Fig 6A). These results indicated that not only VSV M1 but also its shorter forms, M2
and M3, exhibit inhibitory activity on host cell gene expression. Although a direct inhibition of
protein synthesis by M1 has been proposed, it is still unclear whether this is due to the blockade
of mRNA transcription and/or export to the cytoplasm. This uncertainty prompted us to inves-
tigate whether VSV M1, M2 and M3 proteins directly inhibit the translation of exogenous
mRNAs. Thus, BHK-T7 cells expressing different M proteins or PV 2Apro were transfected
with reporter mRNAs encoding luciferase and containing either a cap structure or the EMC-
V-IRES at the 5’ end. The impact of the viral proteins on cap-dependent or IRES-driven trans-
lation was then analyzed by determining luciferase activity. As shown in Fig 6B, PV 2Apro
inhibited cap-dependent translation of luciferase whereas it stimulated IRES-driven luciferase
synthesis. In contrast, VSV M proteins did not significantly impair either cap-mediated or
IRES-dependent translation of luciferase compared with cells transfected with empty plasmid
(Fig 6B). These findings argue against a direct mechanism of inhibition of cell translation by
VSVM proteins.
Trafficking of mRNAs from nucleus to cytoplasm in BHK cells expressing
VSVM proteins
Given the above results, we questioned whether VSV M proteins could interfere with processes
preceding mRNA translation, such as export of RNAs from the nucleus to the cytoplasm. It is
recognized that VSV M1 protein inhibits nuclear-cytoplasmic transport of cellular mRNAs
and U snRNA when expressed in cells in the absence of other VSV proteins [12, 13, 16, 17]. To
address the possibility that M2 and M3 proteins could have similar effects on cellular transport,
an in situ hybridization assay was employed using a fluorescein-labeled oligo (dT) probe that
hybridizes with the poly (A) tail of cellular mRNAs. BHK-T7 cells were transfected with plas-
mids as before and hybridization of oligo (dT) was carried out after cell fixation at 6 hpt. As
expected, the nuclear fluorescein-labeled oligo (dT) signal was increased in the presence of M1
compared with pTM1 control-transfected cells, indicating that the nuclear accumulation of
mRNAs in BHK cells was due to the blockade of their export to the cytoplasm (Fig 7, upper
panels). Interestingly, the oligo (dT) signal was also concentrated in the nucleus of cells
expressing M2 or M3 protein (Fig 7, lower panels). These results suggest that all three VSV M
proteins exhibit similar inhibitory effects on the trafficking of cellular mRNAs and reveals that
the intact N-terminal domain of VSV M1 is dispensable for blocking nuclear-cytoplasm
mRNA trafficking.
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Redistribution of the splicing factor hnRNP H in cells expressing VSVM
proteins
Aside from the negative effect of VSV M1 on host RNA transcription and mRNA export, it has
been reported that VSV infection induces a cytoplasmic relocation of cellular heterogeneous
nuclear ribonucleoproteins (hnRNPs), which are host factors involved in different nuclear
functions including alternative splicing of immature mRNAs [12, 16, 17, 37]. Nevertheless, this
activity has not been assigned to any VSV protein. Relocation of splicing factors might
Fig 6. Effect of VSVM proteins on cap- and IRES-dependent translation. (A) Effect of VSVM proteins on cellular translation. BHK-T7 cells were
transfected with single pTM1 empty, or pTM1 encoding 2Apro (poliovirus 2A protease), M1, M2 or M3. Additionally cells were co-transfected with pTM1-2Apro
as indicated. At 5 hpt, cells were metabolically labelled with [35S]Met/Cys for 1 h. Cell lysates were analyzed by SDS-PAGE (17.5%), fluorography and
autoradiography (above). Integrity of eIF4GI in the same samples was determined byWestern blot using specific antibodies (below). Bands corresponding to
the intact eIF4GI and the C-terminal (ct) product resulting from eIF4GI proteolytic cleavage are indicated on the right. Apparent molecular weights are
indicated on the left. (B) Effect of VSV M proteins on cap-dependent and cap-independent translation. BHK-T7 cells were transfected for 2 h with pTM1
empty or pTM1 encoding 2Apro, M1, M2 or M3 proteins, or left untransfected (-). Transfection medium was removed and cells were incubated with fresh
DMEM for 1 h. Then, cells were re-transfected with cap-luc mRNA (mRNA CAP-luc, upper graph) or EMCV(IRES)-luc mRNA (mRNA EMCV-luc, lower
graph) for 2 h. Finally, cells were harvested, lysed and luciferase activity was measured as described. Mean values from at least three independent
experiments are represented. Error bars indicate standard deviation. (RLU, relative light units).
doi:10.1371/journal.pone.0131137.g006
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represent an additional viral strategy to indirectly block cellular translation. Thus, we examined
whether M1 or its shorter forms, M2 and M3, had the capacity to redistribute nuclear proteins
during viral infection. Since PV 2Apro was recently described to disrupt the distribution of
splicing factors between the nucleus and the cytoplasm [38, 39], it was included as a positive
control. First, we analyzed the effect of VSV M proteins and VSV infection on the distribution
of RNA and export factor binding protein (Ref-1 or Aly), an hnRNP that participates in
mRNA transcription and transport [40]. In mock transfected cells, Ref-1 exhibited a nuclear
distribution pattern that overlapped with the fluorescent nuclear dye To-Pro3 (Fig 8A) [38]. In
Fig 7. Effect of VSVM2 and M3 expression on nucleus-cytoplasm transport of mRNAs. BHK-T7 cells were transfected for 2 h with pTM1 empty (mock)
or pTM1 encoding M1, M2 or M3 proteins. Cells were fixed 6 hpt and in situ hybridization with fluorescein-labeled oligo (dT) probe was carried out to detect
cellular mRNAs. VSV M proteins were visualized by immunofluorescence using specific monoclonal antibodies against M1 (αM) and the corresponding
mouse secondary antibody conjugated to Alexa 555. To-Pro3 was used as a nuclear marker. Images were acquired with a confocal microscope. Merged
images are shown on the right.
doi:10.1371/journal.pone.0131137.g007
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Fig 8. Redistribution of splicing factors Ref-1 and hnRNP H in cells expressing VSVM proteins. BHK-T7 cells were infected with VSV or transfected for
2 h with pTM1 empty (mock) or pTM1 encoding a tagged version of 2Apro (2A-HA), M1, M2 or M3. Cells were fixed at 6 hpi or 6 hpt and immunofluorescence
Activity of VSVM Proteins on Cell Functions
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contrast, in 2A-HA expressing cells, Ref-1 partly relocalized to the cytoplasm (Fig 8B). A simi-
lar localization pattern of Ref-1 was observed upon individual expression of M proteins or in
VSV infected cells (Fig 8A). To corroborate this result, we analyzed the distribution of a second
nuclear splicing factor, hnRNP H, under identical experimental conditions (Fig 8C). As with
the previous finding, hnRNP H was localized to the nucleus of mock infected cells (Fig 8C,
upper panels), and was partly relocated to the cytoplasm after expression of M proteins, and
also in VSV infected cells (Fig 8C). As expected, a dramatic relocation of hnRNP H was
achieved by expression of PV 2Apro (Fig 8D). Quantitation of the distribution of Ref-1 and
hnRNP H between nucleus and cytoplasm showed that the nuclear/cytoplasm distribution
ratios obtained from cells either expressing M proteins, PV 2Apro or infected with VSV were
reduced and statistically different (p< 0.01) from that of control cells transfected with empty
vector (Fig 8E). These results confirm the participation of M protein in the relocalization of dif-
ferent hnRNPs as proposed previously in studies using a VSV M1 variant [37]. Taken together,
these observations provide strong evidence that the individual expression of each VSVM pro-
tein is able to modify the nuclear localization of hnRNPs during VSV infection, and establish a
new function of VSV M2 and M3 proteins that is shared by M1.
Discussion
Viruses have developed different strategies to maximize the coding capacity of their genomes.
The use of non-canonical mechanisms of translation initiation represents a good example of
how multiple viral proteins can be synthesized from a single molecule of viral mRNA. These
mechanisms are also exploited by distinct viruses to abrogate host cell translation [41], and
have been previously described for different mRNAs from animal viruses, including the M
mRNA of VSV, in addition to certain cellular mRNAs [42]. The VSV MmRNA is translated as
a polyprotein (i.e. M1, M2 and M3) although only the function of the full-length M1 protein
has been studied in depth. In this work, we compared the function of VSV M2 and M3 proteins
to that ascribed for M1.
The translation of VSV MmRNA resulted in an unequal and higher proportion of M1 ver-
sus M2 and M3 independently of the expression system employed. This phenomenon was
more notable in VSV infected BHK cells, where the abundance of the smaller M proteins corre-
lated inversely with the distance between the first AUG start codon and the corresponding
internal initiation codons. Considering the leaky scanning mechanism proposed by Jayakar
et al., the internal initiation of M2 and M3 translation was presumably achieved by a reduced
pool of ribosomes that bypass the first and the second AUG codons [8], by a mechanism that
should be independent of the eIF4F complex [43].
This difference in the expression levels of VSVM proteins, although relevant in a physiolog-
ical context during VSV infection, makes a comparative study of their function difficult. For
this reason, we examined the role of M2 and M3 proteins individually synthesized from inde-
pendent mRNAs. Interestingly, translation of M3 was also observed fromM2 mRNA, although
in a reduced quantity compared with M2 translation or when it was synthesized fromM3
mRNA. Similar to M1, expression of M2 and M3 proteins in BHK cells induced cytotoxicity,
which was evident by time-dependent induction of cell rounding, and eventual cell death.
analysis was performed using specific antibodies against VSVM and Ref-1 (A), HA-tag and Ref-1 (B), VSV M and hnRNP H (C) or HA-tag and (D). To-Pro3
was used as nuclear marker. Images were acquired with a confocal microscope. Merged images are shown on the right. E) Quantitation of the nucleus/
cytoplasm distribution of Ref-1 (black bars) and hnRNP H (grey bars). Ref-1 and hnRNP H fluorescence intensity was measured in M1-, M2-, M3-, 2A-HA-
positive or VSV infected cells using the Image J software. Nucleus/cytoplasm ratios are indicated as the mean values of the measurement of three cells. Error
bars indicate standard deviation. Significance of the difference between ratios of mock cells and the indicated samples was assessed by unpaired (two-
tailed) Student t-test. p < 0.01 (Stata Program Version 11.0).
doi:10.1371/journal.pone.0131137.g008
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These data support the participation of M2 and M3 in VSV-induced cytopathogenesis, and val-
idate the suitability of our expression system for the study of VSV M protein function [8].
Analogous to other multifunctional proteins encoded by animal viruses (e.g. viral prote-
ases), VSV M1 protein plays essential roles during the virus replicative cycle and at the same
time interferes with host cell pathways that are deleterious for the establishment of a productive
infection. In addition to its involvement in virus assembly and release, VSV M1 also promotes
budding of intracellular vesicles at the plasma membrane in the absence of other viral proteins
[44–46]. We found that in contrast to viroporins, a family of pore-forming viral membrane
proteins that contribute to virus budding, the mechanism of budding mediated by VSVM1 did
not involve an increase in plasma membrane permeability [44–46]. Moreover, M2 and M3 pro-
teins did not exhibit viroporin-like activity or plasma membrane localization, and did not
induce vesicle budding. These findings confirm that the first 30 amino acids, which are absent
in M2 and M3, selectively confers M1 with an ability to promote budding, and are required for
its transport to the plasma membrane [44–46]. Therefore, it is unlikely that M2 and M3 partici-
pate in the budding of VSV particles. However, all three M proteins showed a perinuclear dis-
tribution and equally affected host cell translation. We explored the possible mechanisms that
account for this inhibition and found that VSV M proteins do not directly block cellular trans-
lation. Several observations are consistent with this assumption. The integrity of the translation
initiation factor eIF4GI, a target of viral proteases from certain RNA viruses (e.g. 2A from
picornaviruses, HIV protease) which induce direct shut-off of cell protein expression [47, 48],
was not altered by VSVM proteins. Moreover, translation inhibition mediated by M proteins
was not equivalent to the profound block exerted by PV 2Apro. Importantly, in contrast to
endogenous mRNAs, the translation of exogenous mRNAs containing either a cap structure or
an IRES was not impaired in cells expressing the VSV M proteins, whereas PV 2Apro sup-
pressed translation in the former case and stimulated cap-independent translation in the latter.
These results indicate that not only VSV M1 but also M2 and M3 proteins interfere with the
preceding steps of gene expression rather than on the translation machinery. It is well estab-
lished that VSV M1 inhibits host transcription [9, 10] as well as nuclear-cytoplasmic RNA
transport, which is dependent on its interaction with the RaeI/Nup98 complex [12, 13, 16, 17].
Recently a mechanism of inhibition has been proposed from crystallography studies of the M/
RaeI/Nup98 complex [49]. M1 mimics the phosphate backbone of nucleic acids and therefore
competes with host cell mRNAs for binding to RaeI. Importantly, biochemical analysis
revealed that the finger region of M1 protein (residues 49–61), and a highly conserved Met51
within it, blocked RaeI RNA binding activity [49]. Our present findings showed that VSV M2
and M3 proteins also block host cell mRNA export. Similar to the mode of action of M1, the
finger domain present in M2 might provide the binding site to RaeI and Nup98. Moreover, the
fact that M3 (residues 51–229) lacks the first amino acids of the finger but still displayed inhibi-
tory function on mRNA export, suggests that M3 meets the minimal and essential structural
features to mimic M1 function. However, further studies are needed to confirm the effect of
VSV M2 and M3 on RaeI/Nup98 function.
An additional level of repression of host gene expression mediated by M1 during VSV infec-
tion is the impairment of mRNA transcription or/and its export by the relocalization of
hnRNPs to the cytoplasm. We found that the splicing factors Ref-1 and, more remarkably,
hnRNP H, were redistributed to the cytoplasm in VSV-infected cells, and this phenomenon
was reproduced by VSVM proteins expressed alone. Previous studies reported that hnRNP A1
export induced by VSV is also dependent on Rae1 and correlates with a delayed induction of
apoptosis by VSV, but not with host cell shut-off [37]. The recent finding that the VSV M1
mutant M51R, defective at blocking host transcription, failed to promote hnRNP A1 relocaliza-
tion, strongly supports the participation of VSV M2 and M3 proteins in the inhibition of
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hnRNP export [37]. This observation also underscores the importance of Met51 and thus the
potential implication of RaeI in the redistribution of nuclear factors induced by VSVM2 and
M3.
In summary, we describe novel functions of two additional matrix proteins, M2 and M3,
expressed during VSV infection by alternative initiation of M mRNA. These viral proteins,
although deprived of the M1 budding activity, might contribute, to a different degree, to
M1-associated cytopathogenicity during VSV infection. We also provide the first evidence that
VSV M2 and M3 suppress cell gene expression by interfering with nucleus-cytoplasmic mRNA
export and the localization of some splicing factors, leading to an eventual defect in cell host
protein synthesis. Finally, we hypothesize that in a physiological context, M2 and M3 could
relieve M1 of its common function to facilitate M1-mediated assembly and budding of new
viral particles. This redundancy of functions exhibited by VSV matrix proteins may represent
an advantageous strategy not only for the establishment of VSV replication but also to ensure
multiple cycles of infection in the host cell.
Materials and Methods
Cell culture and virus stock
Baby hamster kidney (BHK-21 and clone BSR-T7/5, designated as BHK-T7) cells [50] were
used in this work. Cells were grown at 37°C in Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 5% or 10% foetal calf serum (FCS) and non-essential amino acids. BHK-T7
cells were additionally cultured in the presence of 2 mg/ml geneticin (G418, Sigma) on every
third passage. Cells were infected with VSV (Indiana strain) at a multiplicity of infection of
10 pfu (plaque forming units) /cell.
Plasmids
The pTM1-derived expression plasmids containing the coding sequences of VSV M1, M2 or
M3 were constructed using the pBS-GMMG plasmid as a DNA template (kindly provided by
Dr. Whitt, University of Tennessee, USA) with the forward primers 5´NcoIM1 (GCGCGCC
CATGGGCAGTTCCTTAAAGAAGATTCTCG), 5´NcoIM2 (GCGCGCCCATGGAGT
ATGCTCCGAGCGCTCCAATTG), 5´NcoIM3 (GCGCGCCCATGGACACCTATGATCC
GAATCAATTAA), respectively, and the reverse primer 3´BamHI (GCGCGCGGATCCT
TACTAGCTCATTTGAAGTGGCTGATA). PCR products were digested with NcoI/BamHI
restriction enzymes and inserted into the corresponding sites of pTM1. The pTM1-2Apro,
pTM1-2B and pTM1-2C plasmids have been previously described [51–53]. The construct
pKS-luc and pTM1-luc have been described [54]. A SV replicon, pT7repC+M1, was obtained
by cloning the NdeI/BamHI-digested PCR fragment encoding the M1 protein after the
sequence of SV capsid protein (C), into the corresponding sites of plasmid pH30 2J-C [55]. In a
second step, the fragment digested with AatII and XhoI was inserted into the pT7SVwt vector
[55]. Replicons repC and repC+6K have been described [55, 56]. Nucleotide sequences of all
constructs were verified using standard sequencing procedures.
Transfection of mammalian cells
BHK-T7 cells were transfected with 1μg pTM1-based expression vectors using Lipofectamine
2000 (Invitrogen). Alternatively, cells were co-transfected with a combination of two plasmids
(2 μg in total). For RNA transfection, 2 μg of mRNA plus 2 μl Lipofectamine 2000 in Opti-
mem I medium (Invitrogen) were added per well and incubated for 2 h at 37°C. Then, the
transfection mix was removed, and the cells were supplemented with fresh medium containing
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5% FCS. BHK-21 cells were transfected by electroporation with SV-derived replicons or
mRNAs obtained by in vitro transcription, using the corresponding linearized DNA plasmids
as templates. The pKS-luc plasmid was used as a template to obtain cap-luc mRNA. Transcrip-
tion reactions including the cap analog, m7G (5´)ppp(5´)G, were carried out with T7 RNA
polymerase (Promega). In vitro transcription reactions using linearized pTM1-derived plas-
mids did not require the addition of cap analog. Subconfluent BHK cells were electroporated as
described previously [29].
In vitro translation
In vitro translation was carried out in rabbit reticulocyte lysates (RRL, Promega) in the pres-
ence of EasyTagTM EXPRESS 35S Protein Labeling mix, [35S]Met/Cys (Perkin Elmer). In brief,
100 ng of the corresponding mRNA obtained by in vitro transcription was added to the reac-
tion mixture and incubated for 90 min at 30°C. To analyze protein synthesis, samples were
diluted in sample buffer, boiled for 5 min and subjected to SDS-PAGE (15%), followed by fluo-
rography and autoradiography.
Analysis of protein synthesis in BHK cells
Protein synthesis was analyzed at the indicated times by replacing the growth medium with
DMEM without methionine/cysteine and supplemented with [35S]Met/Cys. Cells were col-
lected 45 min later in sample buffer and analyzed as described before. Protein synthesis was
quantified by densitometry of the bands of interest using a GS-800 Calibrated Densitometer
(Bio-Rad).
Western blotting
After SDS-PAGE, proteins were transferred to a nitrocellulose membrane as described [57]. To
detect VSV M proteins, a specific mouse monoclonal antibody, 23H12 clone (generously pro-
vided by Dr. Lyles, Wake Forest School of Medicine, North Carolina, USA) was used at 1:6000
dilution. Incubation with primary antibodies was performed for 2 h at 4°C, and the membrane
was washed three times with PBS containing 0.2% Tween-20 and incubated for 1 h with horse-
radish peroxidase-conjugated anti-mouse antibodies (Promega) at 1:5000 dilution. Finally, the
membrane was washed three times and bound antibodies were detected using the ECL detec-
tion system (Amersham).
Measurement of luciferase activity
Cells transfected with the indicated mRNAs containing the luciferase reporter were lysed in a
buffer containing 25 mM glycylglycine (pH 7.8), 0.5% Triton X-100 and 1 mM dithiothreitol.
Luciferase activity was determined using the luciferase assay system (Promega) and a Monon-
light 2010 apparatus (Analytical Luminescence Laboratory) as described [47, 58].
Membrane permeabilization assay
Transfected cells were seeded in wells of an L-24 plate. At the indicated times, cells were pre-
treated with 0.5 mM hygromycin B (HB, Clontech) for 15 min at 37°C, or left untreated. Then,
proteins were labelled for 40 min with 10 μCi [35S]Met/Cys (Promix; Amersham Pharmacia)
in methionine/cysteine-free DMEM in the presence or absence of 0.5 mMHB. Subsequently,
cells were collected in sample buffer, boiled for 4 min and protein synthesis was analyzed as
described. Protein synthesis was quantified by densitometry of either the band corresponding
to the SV capsid protein (C) or a cellular protein, and was calculated by dividing the values
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obtained for samples treated with HB by the corresponding values obtained from untreated
cells.
Immunofluorescence microscopy and fluorescence in situ hybridization
Fixation and permeabilization of BHK-transfected cells were performed as described [29].
Cells were examined with a confocal LSM510 lens coupled to an Axio Imager Z1 microscope
(Zeiss) with a 63x/1.4 oil Plan-Apochromat objective. Image processing was performed with
Huygens 3.0 software (Scientific Volume Imaging). The following primary antibodies were
used: VSV M-specific mouse monoclonal antibody 23H12 clone (1:800), rabbit antisera against
REF-1/Aly (a generous gift from Elisa Izaurralde, Max Planck Institute for Developmental Biol-
ogy, Tübingen, Germany) and hnRNP H (Abcam), both diluted 1:100. Specific antibodies con-
jugated to Alexa 488 or Alexa 555 (Invitrogen) were used as secondary antibodies at 1:500
dilution. To-Pro-3 (Invitrogen) diluted 1:1000 was used to stain nuclei. Detection of polyade-
nylated mRNAs by fluorescence in situ hybridization (FISH) was carried out with fluorescein-
labeled oligo (dT) (Gene link). Cells were fixed with 4% paraformaldehyde (PFA) for 15 min at
RT, permeabilized with 0.1% Triton in PBS for 10 min and then subjected to three washes:
first, 1× phosphate-buffered saline (PBS), second, 1× PBS and 1× saline-sodium citrate buffer
(SSC), and third, 2× SSC. Cells were then incubated at 37°C with pre-hybridization buffer (2×
SSC, 20% deionized formamide, 0.2% BSA and 1 mg/ml yeast tRNA). Subsequently, cells were
incubated at 37°C for 4 h with hybridization buffer (2× SSC, 20% deionized formamide, 0.2%
BSA, 1 mg/ml yeast tRNA, 10% dextran sulphate and 1 pmol/μl oligo (dT) probe). Preparations
were then washed four times at 42°C for 5 min: the first wash was performed with 2× SSC and
20% formamide; the second with 2× SSC; the third with 1× SSC and 1× PBS; and the last wash
with 1× PBS.
Electron microscopy
Transfected cells were processed for electron microscopy as follows: at 6 hpt, cells were fixed
with 2% glutaraldehyde in 0.2 M HEPES buffer, pH 7.4, for 1 h at room temperature and
immediately scraped off from the plate. Cells were then washed twice and resuspended in 0.2
M HEPES buffer, pH 7.4. After fixation, cells were dehydrated and infiltrated with resin. Thin
sections were obtained and collected on nickel grids. The grids were then incubated for 1 min
in TBS buffer (30 mM Tris-HCl [pH 8.2] containing 150 mMNaCl), followed by 5 min incuba-
tion in TBG buffer (TBS containing 0.1% BSA and 1% gelatin). For immunodetection of VSV
M proteins, M-specific primary antibody was added in TBG buffer and incubated for 1 h.
Subsequently, the grids were washed three times with TBS containing 0.1% BSA followed by
incubation with mouse-specific secondary antibodies bound to 10 nm-gold particles for 1 h.
Finally, grids were washed and examined with a JEM1010 (Jeol) transmission electron micro-
scope equipped with a 4K x 4K TemCam-F416 digital camera (TVIPS GmbH, Gauting,
Germany).
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